Misinformation, hesitancy could blunt impact of new cancer vaccines
Just last month, pharmaceutical companies Moderna and Merck announced that a personalized mRNA cancer vaccine, combined with an immunotherapy drug, had succeeded in a late-stage trial for skin cancer. The news raised hopes that a wave of new cancer vaccines could be just over the horizon.
Original Source
Read the full article at Penncapital-star →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.